Development of multiple malignancies after immunosuppression in a patient with Wegener’s granulomatosis
- 67 Downloads
We describe the development of multiple malignancies in a patient with Wegener’s granulomatosis treated with glucocorticosteroids, azathioprin and cyclophosphamide over 20 years. His symptoms started with a neurological disease, which is unusual. Less attention was paid to other symptoms that occurred simultaneously and were more typical manifestations of the disease. This resulted in delayed diagnosis. Despite incorrect diagnoses, he received appropriate immunosuppressive therapy. After 2 years of therapy, he developed a spinocellular carcinoma, after 12 years a basal cell carcinoma and after 19 years both a Kaposi sarcoma and a urinary bladder carcinoma. This patient illustrates a difficult therapeutic balance between prolonged treatment and the hazards of therapy. No guidelines are established to manage this clinical dilemma.
KeywordsWegener’s granulomatosis Cyclophosphamide Cancer Immunosuppression
We thank Professor V. Finsen for advice regarding the language in this manuscript.
- 2.Stein J, Sridharan ST, Eliachar I, Niv A, Wood B, Hoffman GS (2001) Nasal cavity squamous cell carcinoma in WG. Arch Otolaryngol Head Neck Surg 127:709–713Google Scholar
- 3.Forni AM, Koss LG, Geller W (1964) Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man. Cancer 17:1348–1355Google Scholar
- 5.Stillwell TJ, Benson RC Jr, DeRemee RA, Mc Donald TJ, Weiland LH (1988) Cyclophosphamide-induced bladder toxicity in WG. Arthr Rheum 31:465–470Google Scholar
- 6.Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. (1992) Wegener’s granulomatosis: an analysis of 158 patients. Ann Intern Med 16:488–498Google Scholar
- 10.Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O, et al. (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40:177–186Google Scholar
- 11.Westman KWA, Bygren PG, Olsson H, Ranstam J, Wieslander J (1998) Relapse rate, renal survival and cancer morbidity in patients with WG or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9:842–852Google Scholar
- 12.Katariya K, Thurer RJ (1999) Malignancies associated with the immunocompromised state. Chest Surg Clin N Am 9:63–77Google Scholar
- 13.Deschenes I, Dion L, Beauchesne C, de Brum-Fernandes AJ (2003) Kaposi’s sarcoma following immune suppressive therapy for WG. J Rheumatol 30:622–624Google Scholar